Loading...
50 companies we cover, 48 of them graded
Every company here put through the same five checks on growth and cash generation. It describes the industry as it reports today — not which of these to buy.
| ISRG | Intuitive Surgical, Inc. | A+ | $143.1B | $405.18 | 46.47 | $11B | 28.4% |
| BDX | BECTON, DICKINSON AND COMPANY | B | $50.1B | $183.82 | 55.37 | $23.3B | 4.0% |
| RMD | ResMed Inc. | B+ | $32B | $222.00 | 21.28 | $5.7B | 26.9% |
| ALC | Alcon Inc. | B | $31.4B | $64.47 | 32.56 | $9.5B | 10.3% |
| MDLN | Medline Inc. | C | $29.2B | $34.70 | 24.25 | $28.4B | 4.1% |
| WST | WEST PHARMACEUTICAL SERVICES, INC. | B+ | $26.1B | $370.44 | 47.43 | $3.3B | 17.0% |
| SOLV | SOLVENTUM CORPORATION | F+ | $15.2B | $89.50 | 10.95 | $8.3B | 17.3% |
| BAX | BAXTER INTERNATIONAL INC. | D- | $12.1B | $23.37 | — | $11.5B | -9.3% |
| RGEN | REPLIGEN CORP | A | $10.7B | $189.68 | 259.84 | $785.1M | 5.3% |
| COO | The Cooper Companies, Inc. | A | $10.5B | $55.38 | 18.97 | $4.2B | 13.5% |
| ALGN | ALIGN TECHNOLOGY, INC. | A | $10.4B | $146.78 | 25.57 | $4.1B | 10.0% |
| AVTR | Avantor, Inc. | F | $10.4B | $15.25 | — | $6.6B | -8.4% |
| ATR | AptarGroup, Inc | A | $7.9B | $123.87 | 22.36 | $3.9B | 9.2% |
| STVN | Stevanato Group S.p.A. | C | $6.4B | $21.13 | 36.41 | $1.4B | 11.0% |
| BLCO | Bausch & Lomb Corp | A- | $6B | $16.86 | — | $5.3B | -3.2% |
| MMED | MiniMed Group, Inc. | D- | $5.6B | $19.98 | — | $3.1B | -10.0% |
| MMSI | MERIT MEDICAL SYSTEMS INC | B | $5.2B | $87.50 | 36.01 | $1.6B | 9.2% |
| TFX | TELEFLEX INCORPORATED | C | $5.2B | $122.07 | — | $2.3B | -45.8% |
| ICUI | ICU MEDICAL INC/DE | C | $4.1B | $164.95 | 138.61 | $2.2B | 0.0% |
| NVST | ENVISTA HOLDINGS CORPORATION | A | $3.8B | $23.95 | 41.29 | $2.9B | 3.3% |
| PLSE | Pulse Biosciences, Inc. | D- | $3.7B | $51.63 | — | $1.2M | -6,755.8% |
| WRBY | Warby Parker Inc. | B | $3.4B | $26.71 | 381.57 | $911.6M | 0.8% |
| ATRC | AtriCure, Inc. | A | $3B | $58.38 | 278.00 | $569.6M | 1.9% |
| BLFS | BioLife Solutions, Inc. | A+ | $1.9B | $38.49 | 32.90 | $102.8M | 56.4% |
| XRAY | DENTSPLY SIRONA Inc. | D- | $1.9B | $9.40 | — | $3.6B | -15.0% |
| LMAT | LEMAITRE VASCULAR, INC. | B+ | $1.9B | $81.52 | 28.60 | $262.4M | 25.0% |
| KMTS | Kestra Medical Technologies, Ltd. | D- | $1.6B | $27.14 | — | $106.7M | -140.4% |
| AZTA | AZENTA, INC. | C- | $1.5B | $34.02 | — | $613.8M | -20.0% |
| STAA | STAAR Surgical Co | C | $1B | $20.51 | 256.38 | $339.6M | 1.1% |
| ANGO | AngioDynamics, Inc. | B- | $640.2M | $15.49 | — | $320.2M | -11.5% |
| EMBC | EMBECTA CORP. | D | $334.3M | $5.90 | 4.01 | $1B | 8.6% |
| SMTI | SANARA MEDTECH INC. | A- | $322.1M | $35.06 | — | $109.8M | -29.2% |
| ZJYL | Jin Medical International Ltd. | F | $299M | $1.91 | 191.00 | $20.7M | 5.8% |
| NNNN | Anbio Biotechnology | B+ | $275.1M | $6.30 | 42.86 | $8.6M | 74.1% |
| OSUR | ORASURE TECHNOLOGIES, INC | F- | $271M | $3.93 | — | $112.4M | -43.7% |
| UTMD | UTAH MEDICAL PRODUCTS, INC. | F+ | $236.2M | $74.18 | 22.62 | $36.1M | 29.0% |
| PDEX | PRO-DEX, INC. | A+ | $229.9M | $71.77 | 17.46 | $77.5M | 17.6% |
| KRMD | KORU MEDICAL SYSTEMS, INC. | A- | $148.2M | $3.21 | — | $45.1M | -4.0% |
| STXS | STEREOTAXIS, INC. | F- | $130.3M | $1.30 | — | $30.1M | -74.2% |
| POCI | PRECISION OPTICS CORPORATION, INC. | D- | $50.7M | $4.63 | — | $28.9M | -17.0% |
| DXR | Daxor Corporation | not rated | $46.2M | $11.01 | — | $1.4M | -496.8% |
| NEPH | NEPHROS, INC. | C | $45.9M | $4.23 | 26.44 | $20.7M | 8.4% |
| MLSS | MILESTONE SCIENTIFIC INC. | C- | $36.4M | $0.41 | — | $9.4M | -44.0% |
| HBIO | HARVARD BIOSCIENCE, INC. | F- | $36.2M | $7.96 | — | $87.8M | -11.9% |
| RVP | RETRACTABLE TECHNOLOGIES INC | F- | $21M | $0.70 | — | $33.9M | -9.9% |
| BNGO | Bionano Genomics, Inc. | D- | $19.5M | $1.66 | — | $30.2M | -106.6% |
| FEMY | Femasys Inc. | C- | $8.3M | $2.48 | — | $2.3M | -511.8% |
| CUPR | Cuprina Holdings (Cayman) Limited | F- | $4.8M | $1.87 | — | $39K | -9,366.8% |
| NXGL | NEXGEL, INC. | B- | $1.7M | $0.17 | — | $12.1M | -51.3% |
| RGNT | Regentis Biomaterials Ltd. | not rated | $1.1M | $1.98 | 1.15 | — | — |
Fundamentals from SEC filings, prices from the last market-data pass. Sort by any column; companies with no figure sort last either way.
Sorted by market cap, largest first; click any column to re-sort. Companies with no figure sort last either way, because a missing P/E means unprofitable rather than cheap. Nothing here is a recommendation.